Activity of a novel quinoxaline derivative against human immunodeficiency virus type 1 reverse transcriptase and viral replication.

Ítems similars

• Resistance pattern of human immunodeficiency virus type 1 reverse transcriptase to quinoxaline S-2720.
  per: Balzarini, J, et al.
  Publicat: (1994)
• Preclinical evaluation of HBY 097, a new nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 replication.
  per: Kleim, J P, et al.
  Publicat: (1995)
• Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.
  per: Kleim, J P, et al.
  Publicat: (1996)
• Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease.
  per: Tomasselli, A. G., et al.
  Publicat: (1993)
• Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
  per: Maass, G, et al.
  Publicat: (1993)